Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020

We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Maria Skaalum, Strøm, Marin, Fjallsbak, Jógvan Páll, Hansen, Jóhanna Ljósá, Larsen, Sólrun, Eliasen, Eina H., Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Weihe, Pál
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714219/
https://www.ncbi.nlm.nih.gov/pubmed/34757895
http://dx.doi.org/10.3201/eid2801.210917
_version_ 1784623874044854272
author Petersen, Maria Skaalum
Strøm, Marin
Fjallsbak, Jógvan Páll
Hansen, Jóhanna Ljósá
Larsen, Sólrun
Eliasen, Eina H.
Johansen, Malan
Veyhe, Anna Sofía
Kristiansen, Marnar Fríðheim
Weihe, Pál
author_facet Petersen, Maria Skaalum
Strøm, Marin
Fjallsbak, Jógvan Páll
Hansen, Jóhanna Ljósá
Larsen, Sólrun
Eliasen, Eina H.
Johansen, Malan
Veyhe, Anna Sofía
Kristiansen, Marnar Fríðheim
Weihe, Pál
author_sort Petersen, Maria Skaalum
collection PubMed
description We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
format Online
Article
Text
id pubmed-8714219
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-87142192022-01-04 Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020 Petersen, Maria Skaalum Strøm, Marin Fjallsbak, Jógvan Páll Hansen, Jóhanna Ljósá Larsen, Sólrun Eliasen, Eina H. Johansen, Malan Veyhe, Anna Sofía Kristiansen, Marnar Fríðheim Weihe, Pál Emerg Infect Dis Research Letter We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands. Centers for Disease Control and Prevention 2022-01 /pmc/articles/PMC8714219/ /pubmed/34757895 http://dx.doi.org/10.3201/eid2801.210917 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Petersen, Maria Skaalum
Strøm, Marin
Fjallsbak, Jógvan Páll
Hansen, Jóhanna Ljósá
Larsen, Sólrun
Eliasen, Eina H.
Johansen, Malan
Veyhe, Anna Sofía
Kristiansen, Marnar Fríðheim
Weihe, Pál
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
title Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
title_full Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
title_fullStr Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
title_full_unstemmed Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
title_short Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
title_sort low seroprevalence among undetected covid-19 cases, faroe islands, november 2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714219/
https://www.ncbi.nlm.nih.gov/pubmed/34757895
http://dx.doi.org/10.3201/eid2801.210917
work_keys_str_mv AT petersenmariaskaalum lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT strømmarin lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT fjallsbakjogvanpall lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT hansenjohannaljosa lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT larsensolrun lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT eliaseneinah lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT johansenmalan lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT veyheannasofia lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT kristiansenmarnarfriðheim lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020
AT weihepal lowseroprevalenceamongundetectedcovid19casesfaroeislandsnovember2020

Ejemplares similares